| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |